Research is currently underway to see how BPC-157 therapy can provide even further benefit
[1] NNMT as a Metabolic Research Target Independent research groups have studied NNMT inhibition in diet-induced obese (DIO) mouse models
Practitioners are already using this approach with success in: Autoimmune conditions (like arthritis, Hashimotos, and celiac-related issues) Post-COVID complications (including Long COVID and MIS-C) Metabolic dysfunction (insulin resistance, chronic inflammation) Neurological issues (brain fog, mood changes from gut-brain disruption) What Research Shows Clinical studies on Larazotide demonstrate: A measurable reduction in gut permeability markers Improved gut symptom scores Lower inflammatory cytokine levels A strong safety record with minimal side effects Patients typically notice improvement in 714 days , with full benefits within 46 weeks
Vitamin B12 is essential for converting carbohydrates into glucose, which your body uses for energy
Discuss the risk-benefit ratio with your provider
This expertise ensures that each infusion is tailored to your unique health goals and medical history, minimizing risks and maximizing benefits
